Enovis (ENOV) Liabilities and Shareholders Equity (2010 - 2026)

Enovis (ENOV) reported Liabilities and Shareholders Equity of $3.8 billion for Q2 2026, down 21.39% year-over-year from $4.9 billion in Q2 2025, and little changed quarter-over-quarter from $3.8 billion in Q4 2025.

Enovis (ENOV) Liabilities and Shareholders Equity (2010 - 2026) Analysis & Trends

Enovis (ENOV) has 17 years of Liabilities and Shareholders Equity data on file, last reported at $3.8 billion in Q2 2026.

  • Liabilities and Shareholders Equity for Q2 2026 came in at $3.8 billion, down 21.39% year-over-year; the trailing twelve-month figure through Apr 2026 was $17.1 billion (down 16.83% YoY), and the FY2025 annual result was $3.8 billion, down 18.73% from the prior year.
  • Liabilities and Shareholders Equity steadied at $3.8 billion in Q2 2026 per ENOV's latest filing, from $3.8 billion in the prior quarter.
  • Over five years, Liabilities and Shareholders Equity peaked at $5.6 billion in Q3 2024 and troughed at $2.8 billion in Q2 2022.
  • A 5-year average of $4.5 billion and a median of $4.4 billion in 2022 frame the typical range for Liabilities and Shareholders Equity.
  • The sharpest annual moves came in 2022 and 2023: Liabilities and Shareholders Equity plunged 65.29% in 2022, then soared 53.56% in 2023.
  • A 5-year view of Liabilities and Shareholders Equity shows it stood at $4.3 billion in 2022, then rose by 5.52% to $4.5 billion in 2023, then grew by 4.64% to $4.7 billion in 2024, then retreated by 18.73% to $3.8 billion in 2025, then decreased by 0.06% to $3.8 billion in 2026.
  • Business Quant data shows ENOV's Liabilities and Shareholders Equity at $3.8 billion in Q2 2026, $3.8 billion in Q4 2025, and $4.4 billion in Q4 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Liabilities and Shareholders Equity (Qtr)
1 Abbott Laboratories 154.42 Bn 147.76 Bn 6.27 Bn 110.43 Bn
2 Stryker 118.12 Bn 115.25 Bn 3.81 Bn 46.29 Bn
3 Medtronic 101.72 Bn 93.55 Bn 5.76 Bn 91.49 Bn
4 Boston Scientific 67.19 Bn 65.98 Bn 3.61 Bn 44.35 Bn
5 Edwards Lifesciences 50.69 Bn 47.02 Bn 1.29 Bn 13.32 Bn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 31.92 Bn
7 Dexcom 28.09 Bn 26.97 Bn 750.30 Mn 6.63 Bn
8 GE HealthCare Technologies 28.08 Bn 26.02 Bn 1.98 Bn 37.13 Bn
9 Steris 19.80 Bn 19.37 Bn 697.10 Mn 10.74 Bn
10 Enovis 1.26 Bn 1.23 Bn 365.49 Mn 3.83 Bn

Historic Data

Download Data
DateValue
Apr 3, 2026 3.83 Bn
Dec 31, 2025 3.83 Bn
Oct 3, 2025 4.43 Bn
Jul 4, 2025 5.02 Bn
Apr 4, 2025 4.88 Bn
Dec 31, 2024 4.72 Bn
Sep 27, 2024 5.55 Bn
Jun 28, 2024 5.44 Bn
Mar 29, 2024 5.48 Bn
Dec 31, 2023 4.51 Bn
Sep 29, 2023 4.40 Bn
Jun 30, 2023 4.44 Bn
Mar 31, 2023 4.30 Bn
Dec 31, 2022 4.27 Bn
Sep 30, 2022 4.44 Bn
Jul 1, 2022 4.50 Bn
Apr 1, 2022 2.80 Bn
Dec 31, 2021 8.52 Bn
Oct 1, 2021 7.97 Bn
Jul 2, 2021 7.56 Bn